Your browser doesn't support javascript.
loading
Unmet Needs in Appendiceal Neuroendocrine Neoplasms.
Toumpanakis, Christos; Fazio, Nicola; Tiensuu Janson, Eva; Hörsch, Dieter; Pascher, Andreas; Reed, Nicholas; O Apos Toole, Dermot; Nieveen van Dijkum, Els; Partelli, Stefano; Rinke, Anja; Kos-Kudla, Beata; Costa, Frederico; Pape, Ulrich-Frank; Grozinsky-Glasberg, Simona; Scoazec, Jean-Yves.
Afiliação
  • Toumpanakis C; Neuroendocrine Tumour Unit, Royal Free Hospital, London, United Kingdomc.toumpanakis@ucl.ac.uk.
  • Fazio N; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, Milan, Italy.
  • Tiensuu Janson E; Endocrine Oncology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Hörsch D; Center for Neuroendocrine Tumors Bad Berka, Bad Berka, Germany.
  • Pascher A; Department of Surgery, Campus Charité Mitte/Campus Virchow-Klinikum, Charité University Medicine Berlin, Berlin, Germany.
  • Reed N; Beatson Oncology Centre, Gartnavel General Hospital, Glasgow, United Kingdom.
  • O Apos Toole D; Department of Clinical Medicine, St. James's Hospital, Trinity College Dublin, Dublin, Ireland.
  • Nieveen van Dijkum E; Department of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Partelli S; Pancreatic Surgery Unit, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, "Vita-Salute" University, Milan, Italy.
  • Rinke A; Department of Gastroenterology, UKGM, Marburg, Marburg, Germany.
  • Kos-Kudla B; Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.
  • Costa F; Hospital Sírio-Libanês, São Paulo, Brazil.
  • Pape UF; Division of Hepatology and Gastroenterology, Medical Department, Charité Campus Charité Mitte/Campus Virchow-Klinikum, Charité University Medicine Berlin, Berlin, Germany.
  • Grozinsky-Glasberg S; Neuroendocrine Tumor Unit, Department of Endocrinology, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.
  • Scoazec JY; Department of Pathology, Gustave Roussy Cancer Campus, Villejuif, France.
Neuroendocrinology ; 108(1): 37-44, 2019.
Article em En | MEDLINE | ID: mdl-30235454
Appendiceal neuroendocrine neoplasms (ANEN) are mostly discovered coincidentally during appendicectomy and usually have a benign clinical course; thus, appendicectomy alone is considered curative. However, in some cases, a malignant potential is suspected, and therefore additional operations such as completion right hemicolectomy are considered. The existing European Neuroendocrine Tumour Society (ENETS) guidelines provide useful data about epidemiology and prognosis, as well as practical recommendations with regards to the risk factors for a more aggressive disease course and the indications for a secondary operation. However, these guidelines are based on heterogeneous and retrospective studies. Therefore, the evidence does not seem to be robust, and there are still unmet needs in terms of accurate epidemiology and overall prognosis, optimal diagnostic and follow-up strategy, as well as identified risk factors that would indicate a more aggressive surgical approach at the beginning and a more intense follow-up. In this review, we are adopting a critical approach of the ENETS guidelines and published series for ANEN, focusing on the above-noted "grey areas".
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Apêndice / Tumores Neuroendócrinos Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Apêndice / Tumores Neuroendócrinos Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article